Singapore
· Delayed Price · Currency is SGD Hyphens Pharma International Company Description
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
It operates through Specialty pharma principals; Proprietary brands; and Medical hypermart and digital segments.
The Specialty Pharma Principals segment markets and sells specialty pharmaceutical products, including contrast media products, Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products through distributorship or licensing, and supply agreements for the therapeutic areas, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics.
The Proprietary Brands segment develops, markets, and sells dermatological products, such as Cerdan, TDF, and CG 210 for the treatment of atopic dermatitis, acne, aging skin, and hyperpigmentation, as well as health supplement products under the Ocean Health brand name for heart, joint, physical, cognitive, eye, and children's health.
The Medical Hypermart and Digital segment wholesales pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele sales, direct sales, and online B2B platform.
The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018.
Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
| Country | Singapore |
| Founded | 1998 |
| Industry | Pharmaceutical Preparations |
| Employees | 474 |
| CEO | See Wah Lim |
Contact Details
Address: 16 Tai Seng Street Singapore, 534138 Singapore | |
| Phone | 65 6338 8551 |
| Website | hyphensgroup.com |
Stock Details
| Ticker Symbol | 1J5 |
| Exchange | Singapore Exchange - Catalist |
| Fiscal Year | January - December |
| Reporting Currency | SGD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| See Wah Lim | Chief Executive Officer |
| Yufan Zhang | Chief Financial Officer |
| Yann Alain Marche | Chief Operating Officer |